Sandoz Voluntary Recalls Ranitidine Hydrochloride Capsules Due to Elevated Amount of N-Nitrosodimethylamine in the US

Shots:

• Sandoz recalls all quantities and lots of ranitidine hydrochloride capsules (150/300mg) including 30 count, 60 count and 500 count bottles within expiry to the consumer level due to an elevated amount of impurity of NDMA which is classified as a carcinogen in the US. The recall is being conducted with the knowledge of the US FDA
• Sandoz will be notifying its distributors and customers via overnight mail, Sandoz web site, and will arrange for the return of all recalled products. Consumers can contact Sandoz at 1-800-525-8747 option # between 8:30 am – 5:00 pm Monday – Friday EST or www.us.sandoz.com regarding any query about the recall
• Ranitidine Hydrochloride is an oral therapy, indicated for duodenal ulcer, benign gastric ulcer, reflux esophagitis, post-operative peptic ulcer, Zollinger-Ellison Syndrome and other conditions where reduction of gastric secretion and acid output is required

Click here to­ read full press release/ article | Ref: Sandoz | Image: Finazen